Industry News
Join the 2012 business delegation to BIO
AusBiotech invites you to take part in the BIO International Convention, the largest global event for the biotechnology industry, attracting the biggest names in biotech. [ + ]
Sirtex Medical 1H profit climbs 70%
Sirtex Medical (ASX:SRX) has reported a 69.7% increase in 1H profit, due in part to accelerating sales of its radioactive microsphere treatments for liver cancer. [ + ]
Alchemia granted new US fondaparinux patent
Alchemia Limited (ASX:ACL) has been granted the second of four US patents it has applied for to protect its manufacturing process for the fondaparinux blood clot treatment. [ + ]
LCT posts $8.1m 1H profit on JV deal
Living Cell Technologies (ASX:LCT) swung to an $8.1m profit in 1H12, after selling its DIABECELL assets to its new 50/50 joint venture. [ + ]
Father of DSC awarded 2012 Albert Einstein World Award of Science
A substantial validation of the power of dye solar cell (DSC) technology to significantly impact the world’s renewable energy supply has come from the World Cultural Council, which has awarded Professor Michael Grätzel the prestigious 2012 Albert Einstein World Award of Science for his outstanding achievements in inventing and developing the Grätzel Cell, the Dye-sensitised Solar Cell. [ + ]
Genetic Technologies reports $3.3m 1H loss
Genetic Technologies (ASX:GTG) has reported a $3.3m loss for 1H12, as a result of declining diagnostics and patent licensing revenue. [ + ]
Coridon developing next-gen HPV vaccine
Ian Frazer and the team at Coridon is working on a new vaccine that will also provide treatment for human papillomavirus (HPV) in infected women. [ + ]
Allied announces Coridon to develop HPV therapeutic vaccine
The board of Allied Healthcare Group has announced that its investment company Coridon has embarked on the development of a next-generation therapeutic Human Papillomavirus (HPV) vaccine. The program will be based on preliminary work by Coridon founder Professor Ian Frazer’s team and follows on from Professor Frazer’s work that resulted in two successful cervical cancer preventative vaccines - Gardasil and Cervarix. [ + ]
DuPont and the Australian Centre for Plant Functional Genomics collaborate on wheat production
DuPont and the Australian Centre for Plant Functional Genomics (ACPFG) have expanded their long-standing research collaboration to increase research scale on improving the overall productivity of wheat, as well as other crops. [ + ]
Patent reform bill passes Senate
The Raising the Bar bill, which tightens Australian patent laws, including adding an exemption for researchers, has cleared the Senate and will move to the House of Representatives. [ + ]
Partner & exhibitor packages now open for AusBiotech 2012
Partnership and exhibition packages are now available for the AusBiotech 2012 national conference to be held in Melbourne, Victoria from 30 October to 2 November 2012. [ + ]
Phylogica wins US peptide patent
Perth-based Phylogica (ASX:PYC) has received a US patent for one of its Phylomer library of peptides with potential drug development leads. [ + ]
Ancient penguin DNA is key to conservation
Conservation of the King Penguin is proving successful following research showing that the species has recovered past genetic diversity in just 80 years, despite a prior threat of extinction. [ + ]
Working group on promotion of therapeutic products
Key industry stakeholders have been debating whether or not companies should prescribe to a harmonised code of conduct to achieve TGA registration. [ + ]
NSW Scientist of the Year makes breakthrough in race to develop quantum computer
A team of world-leading Sydney scientists has made a major breakthrough in the race to develop the first quantum computer that will perform tasks a billion times faster than computers today. The team, led by 2011 NSW Scientist of the Year Professor Michelle Simmons, has built the world’s smallest transistor by precisely positioning a single phosphorus atom in a silicon crystal. [ + ]